Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Acyclovir 800 mg vs Zovirax in Healthy Thai Volunteers (Fasting)
TCTR20221121003Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aciclovir (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
aciclovir
Beyond the preview
Go deeper on TCTR20221121003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221121003.